Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence
- PMID: 17943697
- DOI: 10.1055/s-2007-984437
Atypical type II silent corticotrophic adenoma developing into Cushing's disease upon second recurrence
Abstract
Herein, we report the case of a 73-year old male patient who presented with two recurrences of a pituitary adenoma within a period of 15 years. The first tumor resection 15 years ago revealed a non-functioning pituitary macroadenoma. 11 years later, the first recurrence of the tumor was reoperated. Throughout the early course of the disease, he suffered from secondary adrenal insufficiency and required replacement therapy with hydrocortisone. Currently, he presented with the second recurrence and clinical examination revealed signs of Cushing's disease. This was clearly confirmed by endocrinological evaluation. A retrospective analysis of all histological and immunohistochemical slides rendered an adenoma exhibiting chromophobia, ACTH-positivity and features of atypia such as elevated p53 and Ki67 expression as well as nuclear polymorphism. According to the revised WHO classification it was classified as atypical type II silent corticotroph adenoma at the time of the first and second surgery. The specimen removed during the recent surgery displayed the same histological features and was classified as corticotroph adenoma. The combination of an atypical type II adenoma and the switch in the hormone status to an endocrinologically active adenoma makes this case exceedingly rare.
Similar articles
-
Cushing's disease associated with both pituitary microadenoma and corticotroph hyperplasia.Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):289-93. doi: 10.1055/s-0028-1085997. Epub 2008 Oct 1. Exp Clin Endocrinol Diabetes. 2009. PMID: 19085700
-
ACTH- and prolactin-producing pituitary gland microadenoma with biphasic features of atypia and intermediate filament expression.Neuro Endocrinol Lett. 2006 Feb-Apr;27(1-2):89-92. Neuro Endocrinol Lett. 2006. PMID: 16648816
-
FSH-producing macroadenoma associated in a patient with Cushing's disease.Neuro Endocrinol Lett. 2006 Dec;27(6):733-6. Neuro Endocrinol Lett. 2006. PMID: 17187002
-
Somatostatin and somatostatin receptors in Cushing's disease.Mol Cell Endocrinol. 2008 May 14;286(1-2):199-205. doi: 10.1016/j.mce.2007.10.015. Epub 2007 Nov 22. Mol Cell Endocrinol. 2008. PMID: 18221833 Review.
-
Pathophysiology and treatment of subclinical Cushing's disease and pituitary silent corticotroph adenomas [Review].Endocr J. 2014;61(10):941-8. doi: 10.1507/endocrj.ej14-0120. Epub 2014 Jun 29. Endocr J. 2014. PMID: 24974880 Review.
Cited by
-
Subclinical hyperfunctioning pituitary adenomas: the silent tumors.Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22. Best Pract Res Clin Endocrinol Metab. 2012. PMID: 22863387 Free PMC article. Review.
-
The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.Endocrine. 2017 May;56(2):286-297. doi: 10.1007/s12020-016-1028-0. Epub 2016 Aug 4. Endocrine. 2017. PMID: 27491554
-
Cystic versus non-cystic silent corticotrophic adenomas: clinical and histological analysis of 62 cases after microscopic transsphenoidal surgery-a retrospective, single-center study.Sci Rep. 2023 Feb 11;13(1):2468. doi: 10.1038/s41598-023-29628-3. Sci Rep. 2023. PMID: 36774403 Free PMC article.
-
Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.Pituitary. 2018 Feb;21(1):32-40. doi: 10.1007/s11102-017-0844-4. Pituitary. 2018. PMID: 29032459
-
Highly Aggressive and Radiation-Resistant, "Atypical" and Silent Pituitary Corticotrophic Carcinoma: A Case Report and Review of the Literature.Case Rep Oncol. 2019 Feb 8;12(1):139-146. doi: 10.1159/000496019. eCollection 2019 Jan-Apr. Case Rep Oncol. 2019. PMID: 31043952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous